S. Vukelja

Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer

Frankie A. Holmes, Joyce O’Shaughnessy, S. Vukelja et al. · Journal of Clinical Oncology · 2002 · 517 citations

Medicine, Oncology, Pharmacology +17

A phase II study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+ metastatic breast cancer.

S. Vukelja, Hope S. Rugo, C Vogel et al. · Cancer Research · 2009 · 27 citations

Pharmacy, Oncology, Pharmacology +17

Gilbert's syndrome co-existing with and masking hereditary spherocytosis

Sachit Sharma, S. Vukelja, Shailesh C. Kadakia · Annals of Hematology · 1997 · 23 citations

Life Sciences, Genetics, Hematology +3

The effect of tamoxifen (T) or exemestane (E) on bone mineral density (BMD) after 1 year of adjuvant treatment of postmenopausal women with early breast cancer

Stephen E. Jones, James Cantrell, S. Vukelja et al. · Journal of Clinical Oncology · 2005 · 12 citations

Medicine, Oncology, Pharmacotherapy +17

A randomized, multicenter phase III trial comparing doxorubicin + cyclophosphamide followed by paclitaxel or doxorubicin + paclitaxel followed by weekly paclitaxel as adjuvant therapy for high-risk breast cancer

David Loesch, F. Anthony Greco, Joyce O’Shaughnessy et al. · Journal of Clinical Oncology · 2007 · 12 citations

Medicine, Oncology, Pharmacology +17